KFG
BIIB icon

Kingdom Financial Group’s Biogen BIIB Stock Holding History

Kingdom Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.75K Buy
+15
New +$2.76K ﹤0.01% 630

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kingdom Financial Group's BIIB Position: Q1 2026 in Review

Kingdom Financial Group opened a new position in Biogen (BIIB) in Q1 2026: 15 shares worth $2.75K. The stake represents ﹤0.01% of the portfolio and ranks #630 among its holdings.

1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Kingdom Financial Group held 15 shares of Biogen worth $2.75K as of Q1 2026.
  • Biogen was a new Kingdom Financial Group position in Q1 2026.
  • Biogen made up ﹤0.01% of Kingdom Financial Group's portfolio in Q1 2026, its #630 holding.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Kingdom Financial Group's 13F filing for Q1 2026, filed 13 May 2026.